KMA Land2h
Medicare recipients urged to review prescription drug, advantage plans during open enrollment
With open enrollment in full swing, local counselors remind Medicare beneficiaries to review their insurance plans.
insurancebusinessmag2h
Beneva's drug strategy yields $71 million in savings
Alongside biosimilars, Beneva has forged product listing agreements that offer a 12% average discount on more than 50 ...
policymed.com7h
Updates from FDA’s Office of Prescription Drug Promotion: Standards for Direct-to-Consumer Advertising
In a recent presentation at the 25th Annual Pharmaceutical and Medical Device Ethics and Compliance Congress, Catherine Gray, ...
Maryland is taking steps to lower prescription drug prices; Big Pharma isn’t happy about it
It's not surprising that drug makers oppose Maryland's efforts to limit prices of some prescription drugs, write Sean Tunis ...
Gov. Jared Polis cheers RFK Jr.’s nomination for health post despite anti-vaccine statements
After Polis faced pushback Thursday, he added the second X post, which defended vaccine access and science as a cornerstone ...
Bay County re-launches the prescription drug discount card program
PANAMA CITY, Fla. (WJHG/WECP) - Bay County has officially announced the re-launch of the Bay Cares card program.
Free prescription drug discount cards relaunching for Bay County residents
Bay County is relaunching a free prescription drug discount card that could save you and your family an average of 25% off ...
Let The Numbers Speak: Prescription Drug Provisions In The Inflation Reduction Act
The Inflation Reduction Act is unlikely to generate savings for taxpayers, while disrupting the market and creating perverse ...
Overturning Chevron Doctrine Could Impact Medicare’s Drug Selections For Price Negotiations
Courts have long deferred to CMS’s decisions on implementation of laws that govern Medicare. The overturning of the Chevron ...
New FDA rules for TV drug ads: Simpler language and no distractions
FDA’s requirement for truthful, balanced risk and benefit information applies to drugmakers, leaving a loophole for both ...